Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'.

Negative operating cash flowResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹81.50

prior close

₹80.81

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-7.2% vs market

Pharmaceuticals peers, median of 160sector+0.2%-6.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 6.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-4.3

30m

-4.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1+1.1-7.2+0.2-6.3

Next day

-6.2+1.2-7.4+0.2-6.4

-6.3+2.8-9.1+1.5-7.8

-6.1+3.5-9.7+1.4-7.6

-6.1+3.5-9.6+1.6-7.7

-6.1+2.8-9.0+1.0-7.2

-7.5+2.8-10.3+0.4-7.9

15d

-2.5+4.2-6.7+0.7-3.2

-3.2+10.1-13.3+3.1-6.3

-1.4+10.0-11.4+7.2-8.6

-6.3+14.6-20.8+8.2-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma reported annual revenue of Rs 77,166 Lakhs for FY26, up 16.6% from Rs 66,151 Lakhs in FY25. However, profit after tax declined 13.3% to Rs 4,105 Lakhs from Rs 4,735 Lakhs due to higher input costs and raw material expenses. EBITDA margin compressed to 8.56% from 10.64% in the prior year. The company completed a 1:1 bonus share issuance in July 2025, doubling share capital to Rs 5,011 Lakhs. The board recommended a dividend of Rs 1.50 per share. Inventories nearly doubled to Rs 14,776 Lakhs while operating cash flow turned negative at Rs -301 Lakhs due to working capital buildup. Auditors issued an unqualified (clean) opinion.

Likely market impact

While revenue growth demonstrates business expansion, the decline in profitability and margin compression signal cost pressures that concern investors. The sharp rise in inventory and negative operating cash flow may require monitoring. The clean audit opinion provides assurance on financial reporting quality.

By the numbersStandalone · Q4 FY26 vs Q4 FY25

	Q4 FY26	Q4 FY25	Change
Revenue	₹202.1 Cr	₹198.1 Cr	+2.0%
Operating profit	₹16.77 Cr	₹15.88 Cr	+5.6%
Profit after tax	₹11.68 Cr	₹12.46 Cr	−6.2%
EBITDA margin	9.8%	9.4%	+0.4 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.